Welcome to our dedicated page for Wellbeing Digital Sciences news (Ticker: KONEF), a resource for investors and traders seeking the latest updates and insights on Wellbeing Digital Sciences stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Wellbeing Digital Sciences's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Wellbeing Digital Sciences's position in the market.
KetamineOne Capital Limited has announced an innovative breakthrough at its MindScape facility in Houston, Texas, becoming one of the first clinics to integrate Immersive Virtual Reality (IVR) into ketamine-assisted treatments. This R&D initiative aims to enhance patient experiences and improve treatment outcomes. The Company has also appointed Dr. Quang Henderson to its Advisory Board and as Chair of the Clinic Innovation Council, promoting best practices and innovative technologies across its network. This development positions Ketamine One to capture more market share in alternative mental health treatments.
KetamineOne Capital Limited has successfully completed its acquisition of KGK Science Inc. for $1.5M in cash and shares. Additionally, it has entered a definitive agreement to acquire Integrated Rehab and Performance Ltd. (IRP), with a payment structure including $1M in shares and up to 700,000 additional shares based on performance milestones. This strategic move aims to enhance its mental health treatment offerings and expand its network of clinics. The company's name change will also reflect in a new OTC symbol, KONEF, effective June 3, 2021.